Home Stock

Stock Research: Monash IVF Group

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Monash IVF Group

ASX:MVF AU000000MVF3
36
  • Value
    96
  • Growth
    5
  • Safety
    Safety
    14
  • Combined
    27
  • Sentiment
    70
  • 360° View
    360° View
    36
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Monash IVF Group Limited is an Australia-based company specializing in assisted reproductive services and women's imaging. Key businesses include Fertility Solutions, KL Fertility, Monash IVF, Monash IVF KPJ Johor, and Monash Ultrasound for Women. It operates in Australia and Southeast Asia. In the last fiscal year, the company had a market cap of $192 million, profits of $152 million, revenue of $170 million, and 997 employees.

more

ANALYSIS: With an Obermatt 360° View of 36 (better than 36% compared with alternatives), overall professional sentiment and financial characteristics for the stock Monash IVF Group are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Monash IVF Group. The consolidated Value Rank has an attractive rank of 96, which means that the share price of Monash IVF Group is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 96% of alternative stocks in the same industry. The consolidated Sentiment Rank has a good rank of 70, which means that professional investors are more optimistic about the stock than for 70% of alternative investment opportunities. But the consolidated Growth Rank has a low rank of 5, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. The consolidated Safety Rank has a riskier rank of 14, meaning the company has a riskier financing structure than 86 comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Strongest Rank Revenue Growth
Weakest Rank Value
Country Australia
Industry Health Care Facilities
Size Small
Website monashivfgroup.com.au
Index
Monash IVF Group stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
96 83 71 71
Growth
5 5 59 33
Safety
Safety
14 10 17 23
Sentiment
70 77 100 68
360° View
360° View
36 27 78 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
54 85 71 87
Opinions Change
50 50 95 50
Pro Holdings
n/a 33 85 4
Market Pulse
84 86 79 76
Sentiment
70 77 100 68
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
96 83 71 71
Growth
5 5 59 33
Safety Safety
14 10 17 23
Combined
27 14 40 26
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
76 59 53 61
Price vs. Earnings (P/E)
67 77 71 73
Price vs. Book (P/B)
76 52 53 65
Dividend Yield
95 96 92 86
Value
96 83 71 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
4 37 49 27
Profit Growth
22 39 71 39
Capital Growth
66 10 9 7
Stock Returns
4 15 83 99
Growth
5 5 59 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
19 27 36 54
Refinancing
28 6 12 10
Liquidity
34 27 31 27
Safety Safety
14 10 17 23

Similar Stocks

Discover high‑ranked alternatives to Monash IVF Group and broaden your portfolio horizons.

Shionogi

TYO:4507
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Alfresa Holdings

TYO:2784
Country: Japan
Industry: Health Care Distributors
Size: X-Large
Full Stock Analysis

Kyowa Hakko Kirin

TYO:4151
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Astellas Pharma

TYO:4503
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

With good value and positive sentiment, but low growth and risky financing, this combination is generally dangerous as debt requires growth to sustain it. Only investors with a strong belief in future growth potential and a high-risk tolerance should consider this stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews